SEC Form 4 · accession 0001628280-17-008226
NeuroMetrix, Inc. · NURO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy R Surgenor
Director
Period of report
Aug 3, 2017
Accepted (ET)
Aug 7, 2017 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001289850
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $1.93 | Aug 3, 2017 | A | 1,000 | A | — | Aug 3, 2027 | Common Stock | 1,000 | 1,971 | D |
Explanation of responses
- F1This option vests as follows: 25% on August 3, 2018, and 1/16 each quarter thereafter